Europe Respiratory Care Device Market Size, Growth, Share & Trends Analysis
Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The europe respiratory care devices market, valued at USD 5.97 billion in 2025, stood at USD 6.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 8.96 billion by the end of the period. The Europe respiratory care devices market is rapidly expanding due to the increasing use of these devices to tackle chronic respiratory disorders such as COPD, asthma, and sleep apnea. These diseases are mainly caused by factors like aging populations, continuous smoking habits, and increasing air pollution in several European countries. Products such as assisted ventilation, oxygen therapy, and respiratory monitoring equipment are the topmost in-demand due to a number of elderly people, the segment most vulnerable to respiratory diseases. Continuous innovations in the form of portable oxygen concentrators, smart inhalers, and digitally connected ventilators are not only enhancing the efficiency and patient compliance but also leading to a rise in usage both in hospital and home care settings. Additionally, the shift to home-based care and remote patient monitoring is facilitating the use of respiratory devices in non-clinical settings.
KEY TAKEAWAYS
-
By CountryBased on country, in 2025, Germany accounted for the largest share of 25.6% of the Europe respiratory care devices market.
-
By ProductBased on product, the therapeutic respiratory care devices segment accounted for a larger share of 55.6% of the Europe respiratory care devices market in 2025.
-
By Disease IndicationBased on disease indication, in 2025, the COPD segment accounted for the largest share in the Europe respiratory care devices market
-
By End UserBased on end user, the hospitals segment accounted largest share of 68.8% in the Europe respiratory care devices market druing the forecast period
-
COMPETITIVE LANDSCAPEKoninklijke Philips N.V. and Medtronic were recognized as star players due to their established strong product portfolio.
-
COMPETITIVE LANDSCAPERespiQ have established themselves as among startups and SMEs due to their strong product portfolio and business strategy.
Europe's market for respiratory devices keeps on expanding at a slow but steady pace. The main reason for this market trend is that the incidence of respiratory diseases like COPD, asthma, and sleep apnea has been increasing in the population. Elderly people who are most susceptible to respiratory diseases, habitual smokers and the increase of air pollution in the environment are the leading factors that contribute to the development of such diseases. Hence, the call for ventilators, oxygen therapy equipment, and respiratory monitoring solutions is very high. Further, the rapid technological changes are producing opportunities for the creation of new drug delivery systems and treatments that patients can conveniently use at their own homes, for example, portable oxygen concentrators, smart inhalers, and digitally assisted ventilators which significantly improve the treatment effectiveness as well as patient compliance.When that happens, it naturally results in greater utilization of both hospital and homecare facilities. Moreover, the preference for home care and the adoption of remote patient monitoring have been driving the use of medical devices beyond the traditional clinical settings. On top of that, the well, established healthcare systems, generous reimbursement schemes in different European countries, and a strengthened, post, pandemic, focus on respiratory preparedness and chronic disease management, are together laying the foundation for continued investment in and delivery of respiratory care solutions.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The market for respiratory care devices is rapidly evolving as new technologies and models of care delivery continue to change the ways in which healthcare providers diagnose, treat, and monitor respiratory diseases. Ultimately, it is their customers, i.e. hospitals and centers for ambulatory surgery, specialized clinics, and home healthcare providers, whose decisions are increasingly shaped by trends such as the shift to portable and connected devices, the rise of home, based respiratory care, and the implementation of digital monitoring and smart alarm systems. These changes are necessitated by the requirements for more precise respiratory monitoring, sooner identification of patient's worsening condition, better patient safety during anesthesia and sedation, and increased workflow efficiency for clinicians. Hence, decisions regarding purchases are no longer made solely on the basis of the main equipment but are largely influenced by what comprise the solutions for remote monitoring, patient adherence, and the smooth integration of connected care environments, all with the aim of reducing complications, thus lowering the length of hospital stays, and improving clinical outcomes overall.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing prevalence of respiratory diseases

-
Growing elderly population
Level
-
High Device & Maintenance Costs
Level
-
Growth in Remote Monitoring & Digital Health
-
Expansion of homecare services
Level
-
Intense Competition
-
Complexities in clinical integration
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing prevalence of respiratory diseases
The increase in respiratory diseases is one of the most significant factors that the Europe respiratory care devices market is depending on. The reason patients with conditions such as COPD, asthma, sleep apnea, or other chronic lung disorders are on the rise in the region. The major reasons behind the trend are the ageing populations, long exposure to air pollution, smoking habits, and occupational respiratory risks. When the number of patients with chronic respiratory diseases increases, the need for continuous diagnosis, treatment, and monitoring also increases, which in turn increases the demand for ventilators, oxygen therapy systems, nebulizers, and CPAP/BiPAP devices. In addition, most of these illnesses are not curable by a short, term treatment but require a lifelong management, which means the respiratory care equipment will be used continuously and repeatedly in the hospitals and the homes. This growing number of patients therefore generates a stable and long, term demand for respiratory care technologies, and thus the market growth is highly dependent on the prevalence of the diseases.
Restraint: High Device & Maintenance Costs
The high price of the device and its maintenance charges stand as a major obstacle in the Europe respiratory care devices market since respiratory advanced devices such as ventilators, high, flow oxygen systems, and connected monitoring devices entail a big initial capital and continuously high operational expenses. The first outlay is not the only cost hospitals and homecare providers face when they purchase these devices, they also have to meet the costs of regularly servicing, software upgrading, calibrating, and going pack to consumables such as sensors, masks, and tubing. Spending at this level can limit the capability of smaller hospitals, clinics, and homecare providers to acquire new and technologically advanced systems. In addition, reimbursement differences between European countries may not always fully cover the cost of the more expensive devices, thus, making affordability a problem for both healthcare providers and patients. Therefore, an expensive buying and maintaining a device can be a reason to slow down replacement cycles and limit market penetration mainly in cost, sensitive healthcare settings.
Opportunity: Growth in Remote Monitoring & Digital Health
Remote monitoring and digital health expansion through Europe respiratory care devices market are leading to an enormous opportunity of the industry as healthcare systems are going to connected and data, driven care models. Cloud platforms, IoT, enabled sensors, and mobile health apps' advances allow respiratory equipment like ventilators, CPAP devices, and oxygen concentrators to send live patient data to physicians for constant monitoring and early diagnosis. Thus, managing chronic diseases such as COPD and sleep apnea can be done outside hospital settings, thereby reducing unnecessary hospital visits and providing personalized treatment plans. The development of telehealth services and home, based care throughout Europe is a great promoter of smart, digitally integrated respiratory devices demand. While providers and payers are aiming at the betterment of outcomes at the same time cost control, digital respiratory care solutions may be a considerable source of innovation, new service models, and a sustained market growth.
Challenge: Intense Competition
The market for respiratory care devices in Europe faces a major challenge due to intense competition. The market is dominated by several large multinational players and numerous local manufacturers that all produce similar product categories such as ventilators, oxygen therapy systems, and sleep apnea devices. This overcrowded competitive landscape exerts strong pricing pressure and thus, companies find it difficult to keep high profit margins, especially when hospitals and healthcare providers favor cost, efficient purchasing. To set themselves apart, manufacturers need to make substantial and continuous investments in research and development, digital features, and product innovation, which raises their operating costs. Moreover, frequent product upgrades and fast, paced technological change lead to shorter product life cycles, thus companies have to innovate rapidly in order to remain relevant. Therefore, the competition being so intense, the market is not easily accessible for new entrants and the existing players are being continually pressed to find a right mix of affordability, innovation, regulatory compliance, and at the same time, keeping their market shares.
EUROPE RESPIRATORY CARE DEVICE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Sleep apnea masks are patient interfaces that can be used with a CPAP or BiPAP device to deliver continuous positive pressure to the airway and keep the airway open during sleep in patients with obstructive sleep apnea. These masks are intended to be used every night for a long time, both at home and in clinical sleep therapy settings. | Improve airway patency and decrease apnea events, enhance patient comfort and therapy compliance, and help effective long, term management of sleep, disordered breathing. |
|
|
Pulse oximetry devices are non, invasive sensors that measure and monitor the patients blood oxygen saturation (SpO2) and pulse rate continuously, thus enabling patient monitoring in hospital wards, ICUs, emergency departments, and homecare environments. | Allow early detection of hypoxemia, facilitate timely clinical intervention, increase patient safety, and help clinicians to monitor respiratory and cardiovascular status in real time. |
|
|
Mechanical ventilators are used in assisted or controlled breathing modes to support patients that have respiratory failure or are unable to breathe adequately due to lung damage or other reasons in intensive care units and emergency care settings. | Provide sufficient oxygenation and ventilation, lower breathing work, help recovery in critical cases, and give the possibility of accurate control of respiratory parameters for optimal patient care. |
|
|
Humidifiers are respiratory therapy devices that are used to add heat and moisture to inhaled gases to prevent drying out of the airways and thus increase patient comfort during oxygen therapy and ventilation. | Increase patient comfort, lessen airway irritation, facilitate secretion clearance, and help the respiratory therapy be more effective and of longer duration. |
|
|
Emergency and transport ventilators are devices that provide portable respiratory support to patients during pre, hospital care, inter, facility transfer, and emergency response situations. | Provide stable ventilation during transport, allow quick response in emergencies, increase patient survival and safety, and maintain continuity of care outside the traditional hospital settings. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The European respiratory care devices market ecosystem is a comprehensive network which includes manufacturers, distributors, end users, and regulators. These players collectively determine product development, market access, and adoption. Global top manufacturers like Philips, Drger, Medtronic, GE HealthCare, Masimo, ResMed, Fisher & Paykel Healthcare, Teleflex, Nihon Kohden, and Getinge, are a major source of innovation in ventilators, oxygen therapy systems, monitoring devices, and airway management solutions. These healthcare devices are delivered to healthcare practitioners through the distributors such as Philips, Medtronic, Vision Medical Technologies, and AbMedica, thus providing wide geographical coverage and service support. Most of the demand comes from big hospitals, university medical centers, and national health systems like NHS that depend on respiratory care devices for critical care, anesthesia, and chronic disease management. Regulatory bodies such as EU MDR, European Medicines Agency, and national authorities, are responsible for ensuring that the products meet stringent safety and performance standards. They also have an impact on time, to, market and innovation strategies across the ecosystem while keeping a high level of product quality in the industry.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Europe Respiratory Care Devices Market, By Product
In the product segment, therapeutic respiratory care devices accounted for the largest share in the Europe respiratory care devices market. This is mainly because such devices are directly involved in the treatment and play a major role in the long, term management of the most common and high, burden respiratory diseases, such as COPD, asthma, pneumonia, and sleep apnea. Ventilators, oxygen therapy systems, nebulizers, and CPAP/BiPAP machines are some of the devices that not only help in acute care settings at hospitals and intensive care units but also in long, term care, especially in home healthcare. The growing number of elderly people and the increasing incidences of chronic respiratory diseases in the region have made it imperative for these therapeutic products to be used for the continuous management of diseases and respiratory support. Moreover, the rising trend of home care has increased the demand for therapeutic devices that are portable and user, friendly, while, ongoing technological innovations, such as compact oxygen concentrators and smart ventilators, have further increased their usage. Therefore, therapeutic respiratory care devices dominate the product segment as these devices are almost compulsory in improving patient outcomes and thus alleviating the strain on healthcare systems.
Europe Respiratory Care Devices Market, By Disease Indication
Within the Europe respiratory care devices market, COPD currently takes the lion's share of the disease indication segment largely because of it being common and a long, term respiratory condition mostly found in the elderly population of the region. There is a large base of COPD patients in Europe due to such factors as high smoking rates, prolonged exposure to air pollution, and occupational respiratory hazards. The management of COPD is very much a case of Pt continual and long, term dependency on respiratory care devices like oxygen therapy systems, nebulizers and non, invasive ventilation devices both in hospital and home care settings. Moreover, as the disease frequently worsens, there are more hospital admissions where a higher usage of ventilators and respiratory monitoring equipment in acute care is observed. The demand for respiratory care devices for the treatment of COPD remains higher than for other respiratory ailments due to the disease being chronic as well as progressive, improved rates of diagnostics, increasing disease recognition, and wider availability of home, based respiratory therapies, which has made the COPD disease indication segment still the Euro market dominant one.
Europe Respiratory Care Devices Market, By End User
In the Europe respiratory care devices market, hospitals dominate the end, user segment as they are the first point of contact for diagnosing and treating various respiratory diseases, both acute and chronic, like COPD, pneumonia, ARDS, and sleep, related breathing disorders. Being the major centers for respiratory emergencies and critically ill patients, hospitals create the highest demand for ventilators, oxygen delivery systems, nebulizers, and the most complicated respiratory monitoring devices in intensive care units, operating rooms and emergency departments. The presence of highly trained respiratory specialists and the physically advanced medical infrastructure are additional factors that allow a higher degree of device usage in hospitals. Moreover, as a result of enhanced post, COVID readiness, a lot of European hospitals have increased their capacity for critical care and brought the respiratory equipment up, to, date. The continuous increase of respiratory, related hospital admissions along with technological advancements and investment in hospital infrastructure have made hospitals maintain the status of the most important end, user group in the European respiratory care devices market.
REGION
Germany held the largest share in Europe Respiratory Care Devices Market in 2025
Germany is at the frontrunning position in the Europe respiratory care devices market mainly because it has first, class healthcare infrastructure that is backed by high healthcare spending and also a large share of the population in the country who have chronic respiratory diseases like COPD, asthma, and sleep apnea. There is a very high demand for ventilators, oxygen therapy devices, and advanced respiratory monitoring systems in the country because it has an extensive network of hospitals and a huge number of intensive care units. Besides respiratory diseases among the elderly population of Germany is also a strong factor that helps to increase the number of respiratory diseases, thus the usage of both therapeutic and diagnostic respiratory devices remains continuous. Favorable reimbursement policies and the fast, tracking of technological medical innovations service the market expansion. Moreover, the location of world leading medical device manufacturers and Germany's focused efforts on clinical innovation and quality standards contribute to an early application of advanced respiratory care solutions, which has helped the country maintain its top position in the European respiratory care devices market.

EUROPE RESPIRATORY CARE DEVICE MARKET: COMPANY EVALUATION MATRIX
In the Europe respiratory care devices market matrix, Koninklijke Philips N.V. (Star) leads with scale, extensive distribution, and a comprehensive portfolio of monitoring solutions. Masimo (Emerging Leader) is gaining momentum by offering innovative capnography devices that enhance clinical accuracy, improve patient safety, and support efficient respiratory monitoring. While Koninklijke Philips N.V. dominates through its regional reach and established presence, Masimo's focus on technological innovation positions it for rapid growth toward the leaders’ quadrant.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2025 (USD Billion) | 5.97 |
| Revenue Forecast in 2031 (USD Billion) | 8.96 |
| Growth Rate | CAGR of 7.2% from 2026-2031 |
| Actual data | 2025-2031 |
| Base year | 2025 |
| Forecast period | 2026-2031 |
| Units considered | Value (USD Million), Volume (Thousand Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope | Germany, UK, France, Spain, Italy, and rest of Europe |
| Parent & Related Segment Reports |
Respiratory Care Devices Market US Respiratory Care Device Market Asia Pacific Respiratory Care Device Market North America Respiratory Care Device Market |
WHAT IS IN IT FOR YOU: EUROPE RESPIRATORY CARE DEVICE MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Further breakdown of other applications in the market | Insights on other applications involved in the market |
| Company Information | Market Share Analysis, By Countries (Germany and UK) & Competitive Leadership Mapping for Established Players in the market | Insights on market share analysis by country |
| Geographic Analysis | Further breakdown of the Rest of Europe respiratory care devices market into Russia, Switzerland, Denmark, Austria, and others | Country-level demand mapping for new product launches and localization strategy planning |
RECENT DEVELOPMENTS
- September 2025 : The broader collaboration between Masimo and Koninklijke Philips N.V. merges their leverage in the European respiratory care devices market, through accelerated development and adoption of next generation monitoring and respiratory solutions. The main aim of this partnership is to enable quicker integration of state of the art sensor technologies and connected monitoring platforms into respiratory care systems, thus facilitating hospitals in Europe to manage ventilation more efficiently, enhance patient safety and clinical efficiency, while being in line with the trend of smart, digitally enabled respiratory care.
- March 2025 : ResMed's brand evolution announcement is a significant step that consolidates its position in the European respiratory care devices market. The company has unified its product portfolio under the same ResMed name, which will make the brand more recognizable to both healthcare professionals and patients. This initiative goes hand in hand with the increased use of its sleep and respiratory therapies, especially in homecare and digital health areas, and it also facilitates their expansion of connected breathing and sleep solutions in European markets.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current Eurpoe respiratory care devices market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary research process involved the use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and companies' SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Eurpoe respiratory care devices market. It was also used to obtain important information on key players, market classification, and segmentation aligned with industry trends to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the Eurpoe respiratory care devices market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.
A breakdown of the primary respondents for the Eurpoe respiratory care devices market is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the regional market value, annual revenues were calculated using revenue mapping for major product manufacturers and OEMs active in the Eurpoe respiratory care devices market. All the major product manufacturers were identified at the country level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the Eurpoe respiratory care devices market was split into various segments and subsegments based on:
- List of major players operating in the products market at the country level
- Product mapping of various US respiratory care device manufacturers at the country level
- Mapping of annual revenue generated by listed major players from US respiratory care devices (or the nearest reported business unit/product category)
- Revenue mapping of major players covered
- Extrapolation of the revenue mapping of the listed major players to derive the US market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the Eurpoe respiratory care devices market
The consolidated data was enhanced with detailed insights and analysis from MarketsandMarkets and presented in this report.
Top-Down and Bottom-Up Approach

Data Triangulation
After determining the overall size of the Eurpoe respiratory care devices market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Respiratory care is a healthcare specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of cardiopulmonary system diseases and disorders. Respiratory care devices are widely used in general & surgical wards and ICUs as a life-support measure.
Key Stakeholders
- Respiratory care device manufacturers and distributors
- Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
- Research institutes
- Contract manufacturing organizations (CMOs)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Report Objectives
- To define, describe, and forecast the Eurpoe respiratory care devices market based on product, disease indication, and end user
- To forecast the market size in the US
- To strategically analyze industry trends, technology trends, pricing analysis, regulatory landscape, supply/value chain, ecosystem mapping, Porter’s Five Forces, patent analysis, key stakeholders, buying criteria, and conference & events
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall Eurpoe respiratory care devices market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To strategically profile key players in the Eurpoe respiratory care devices market and comprehensively analyze their core competencies
- To track and analyze competitive developments, including product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions, across the overall Eurpoe respiratory care devices market
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
- To analyze the impact of generative AI on the Eurpoe respiratory care devices market
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
COMPETITIVE LANDSCAPE ASSESSMENT
- Market share analysis, by country (US), which provides market shares of the top 3–5 key players in the Eurpoe respiratory care devices market
- Competitive leadership mapping for established players in the Eurpoe
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Europe Respiratory Care Device Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Europe Respiratory Care Device Market